Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

被引：1
|
作者：
Sharon, David [1 ]
Chan, Steven M. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
MOLECULAR & CELLULAR ONCOLOGY | 2020年 / 7卷 / 02期
基金：
加拿大健康研究院;
关键词：
Acute myeloid leukemia; BCL-2; inhibitor; drug resistance; integrated stress response; antibiotics; mitochondrial translation; ABT-199;
D O I：
10.1080/23723556.2020.1712182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resistance in AML cells through activation of the integrated stress response.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting Apoptosis Pathways in Acute Myeloid Leukemia
    Strati, Paolo
    DiNardo, Courtney
    Daver, Naval
    Andreeff, Michael
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S53 - S54
  • [42] Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia
    Kobayashi, Takahiro
    Sato, Honami
    Miura, Masatomo
    Fukushi, Yayoi
    Kuroki, Wataru
    Ito, Fumiko
    Teshima, Kazuaki
    Watanabe, Atsushi
    Fujishima, Naohito
    Kobayashi, Isuzu
    Kameoka, Yoshihiro
    Takahashi, Naoto
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 285 - 296
  • [43] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    DiNardo, C. D.
    Jonas, B. A.
    Pullarkat, V.
    Thirman, M. J.
    Garcia, J. S.
    Wei, A. H.
    Konopleva, M.
    Doehner, H.
    Letai, A.
    Fenaux, P.
    Koller, E.
    Havelange, V.
    Leber, B.
    Esteve, J.
    Wang, J.
    Pejsa, V.
    Hajek, R.
    Porkka, K.
    Illes, A.
    Lavie, D.
    Lemoli, R. M.
    Yamamoto, K.
    Yoon, S. -S.
    Jang, J. -H.
    Yeh, S. -P.
    Turgut, M.
    Hong, W. -J.
    Zhou, Y.
    Potluri, J.
    Pratz, K. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
  • [44] Venetoclax-containing regimens in acute myeloid leukemia
    Aldoss, Ibrahim
    Pullarkat, Vinod
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [45] Outpatient initiation of venetoclax in patients with acute myeloid leukemia
    Palmer, Shannon
    Patel, Anand
    Wang, Christopher
    Patel, Bianka
    Zeidner, Joshua
    Foster, Matthew
    Muluneh, Benyam
    Buhlinger, Kaitlyn
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1590 - 1598
  • [46] The Growing Role of the BH3 Mimetic Drug Venetoclax in the Therapy of Acute Myeloid Leukemia
    Pelosi, Elvira
    Castelli, Germana
    Testa, Ugo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14 : 1 - 23
  • [47] Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America
    Gomez-De Leon, Andres
    Demichelis-Gomez, Roberta
    Pinedo-Rodriguez, Alfredo
    Enriquez-Vera, Daniel
    Flores-Jimenez, Juan Antonio
    Ceballos-Lopez, Adrian Alejandro
    Rodriguez-Mejorada, Margarita
    Herrera Riojas, Miguel Angel
    Ovilla-Martinez, Roberto
    Baez-Islas, Pamela
    Cota-Rangel, Xochitl
    Neme-Yunes, Yvette
    Inclan-Alarcon, Sergio
    Lopez-Flores, Nelson J.
    Colunga-Pedraza, Perla R.
    Rodriguez-Zuniga, Anna C.
    Gomez-Almaguer, David
    HEMATOLOGY, 2022, 27 (01) : 249 - 257
  • [48] Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
    Pei, Shanshan
    Pollyea, Daniel A.
    Gustafson, Annika
    Stevens, Brett M.
    Minhajuddin, Mohammad
    Fu, Rui
    Riemondy, Kent A.
    Gillen, Austin E.
    Sheridan, Ryan M.
    Kim, Jihye
    Costello, James C.
    Amaya, Maria L.
    Inguva, Anagha
    Winters, Amanda
    Ye, Haobin
    Krug, Anna
    Jones, Courtney L.
    Adane, Biniam
    Khan, Nabilah
    Ponder, Jessica
    Schowinsky, Jeffrey
    Abbott, Diana
    Hammes, Andrew
    Myers, Jason R.
    Ashton, John M.
    Nemkov, Travis
    D'Alessandro, Angelo
    Gutman, Jonathan A.
    Ramsey, Haley E.
    Savona, Michael R.
    Smith, Clayton A.
    Jordan, Craig T.
    CANCER DISCOVERY, 2020, 10 (04) : 536 - 551
  • [49] Venetoclax resistance in acute myeloid leukaemia-Clinical and biological insights
    Nachmias, Boaz
    Aumann, Shlomzion
    Haran, Arnon
    Schimmer, Aaron D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1146 - 1158
  • [50] Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
    Ralf Buettner
    Le Xuan Truong Nguyen
    Corey Morales
    Min-Hsuan Chen
    Xiwei Wu
    Lisa S. Chen
    Dinh Hoa Hoang
    Servando Hernandez Vargas
    Vinod Pullarkat
    Varsha Gandhi
    Guido Marcucci
    Steven T. Rosen
    Journal of Hematology & Oncology, 14
12345